NCT01630278View on ClinicalTrials.gov

Early Ibuprofen Treatment of Patent Ductus Arteriosus (PDA) in Premature Infants (TRIOCAPI)

PHASE3CompletedINTERVENTIONAL
Enrollment

363

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Patent Ductus Arteriosus
Interventions
DRUG

Ibuprofen

Very premature infants with a large ductus, selected by an early echocardiogram, will receive ibuprofen before 12 hours of life

DRUG

Placebo

Very premature infants with a large ductus, selected by an early echocardiogram, will receive placebo before 12 hours of life

Trial Locations (11)

Unknown

University Hopsital, Angers

University Hopsital, Bordeaux

University Hospital, Créteil

University Hospital, Grenoble

University Hospital, Lille

University Hospital, Marseille

Univesity Hospital, Montpellier

University Hospital, Nantes

University Hospital (AP-HP Groupe hospitalier), Paris

University Hospital, Rennes

University Hospital, Tours

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT01630278 - Early Ibuprofen Treatment of Patent Ductus Arteriosus (PDA) in Premature Infants (TRIOCAPI) | Biotech Hunter | Biotech Hunter